Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses

BackgroundCirculating tumour DNA (ctDNA) has been established as a promising (prognostic) biomarker with the potential to personalise treatment in cancer patients. The objective of this systematic review is to provide an overview of the current literature and the future perspectives of ctDNA in non-...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Jan M. van Rees, Lissa Wullaert, Alexander A. J. Grüter, Yassmina Derraze, Pieter J. Tanis, Henk M. W. Verheul, John W. M. Martens, Saskia M. Wilting, Geraldine Vink, Jeroen L. A. van Vugt, Nick Beije, Cornelis Verhoef
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2023-01-01
Seri Bilgileri:Frontiers in Oncology
Konular:
Ctdna (circulating tumour DNA)
cfDNA (circulating free DNA)
rectal cancer
minimal residual disease (MRD)
liquid biopsy
Online Erişim:https://www.frontiersin.org/articles/10.3389/fonc.2023.1083285/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1083285/full

Benzer Materyaller